Hydrogen Bonding Compensation on the Convex Solvent-Exposed Helical Face of IA 3 , an Intrinsically Disordered Protein
Hydrogen Bonding Compensation on the Convex Solvent-Exposed Helical Face of IA 3 , an Intrinsically Disordered Protein
复制标题
本质无序蛋白质 IA 3 暴露于溶剂的凸螺旋面上的氢键补偿
DOI:
10.1021/acs.biochem.3c00169
复制
发表时间:
2023
期刊:
影响因子:
2.9
通讯作者:
Fanucci, Gail E.
中科院分区:
文献类型:
--
作者:
Dunleavy, Katie M.;Oi, Collin;Li, Tianyan;Secunda, Andrew;Jaufer, Afnan M.;Zhu, Yinlu;Friedman, Lee;Kim, Alexander;Fanucci, Gail E.
Saccharomyces cerevisiaeIA3is a 68 amino acid peptide inhibitor of yeast proteinase A (YPRA) characterized as a random coil when in solution, folding into an N-terminal amphipathic alpha helix for residues 2–32 when bound to YPRA, with residues 33–68 unresolved in the crystal complex. Circular dichroism (CD) spectroscopy results show that amino acid substitutions that remove hydrogen-bonding interactions observed within the hydrophilic face of the N-terminal domain (NTD) of IA3-YPRA crystal complex reduce the 2,2,2-trifluoroethanol (TFE)-induced helical transition in solution. Although nearly all substitutions decreased TFE-induced helicity compared to wild-type (WT), each construct did retain helical character in the presence of 30% (v/v) TFE and retained disorder in the absence of TFE. The NTDs of 8 differentSaccharomycesspecies have nearly identical amino acid sequences, indicating that the NTD of IA3may be highly evolved to adopt a helical fold when bound to YPRA and in the presence of TFE but remain unstructured in solution. Only one natural amino acid substitution explored within the solvent-exposed face of the NTD of IA3induced TFE-helicity greater than the WT sequence. However, chemical modification of a cysteine by a nitroxide spin label that contains an acetamide side chain did enhance TFE-induced helicity. This finding suggests that non-natural amino acids that can increase hydrogen bonding or alter hydration through side-chain interactions may be important to consider when rationally designing intrinsically disordered proteins (IDPs) with varied biotechnological applications.